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Abstract
The Newborn Hearing Screening Programme (NHSP) was established in Cork University Maternity Hospital (CUMH) in
April 2011. Between April 2011 and July 2014, 42 infants were identified with a Permanent Childhood Hearing Impairment
(PCHI). Following this diagnosis, infants underwent a paediatric assessment according to recognised guidelines with the
intention of identifying the underlying aetiology of the PCHI. The aim of this study was to assess the findings of this
aetiological workup via retrospective chart review. PCHI data was obtained from the eSP database. This is a web based
information system (eSP) used to track each baby through the screening and referral process A retrospective chart review
of these patients was performed. Sixteen (38%) infants were diagnosed with a bilateral sensorineural hearing loss. Two
infants had congenital CMV infection. A Connexin 26 gene mutation was detected in one infant. Two infants were
diagnosed with Waardenburg syndrome, One with Pendred syndrome and one with Pfeiffer syndrome. Five babies
underwent cochlear implantation. Through adherence to the recommended protocol a possible cause of PCHI may be
determined. This study has identified areas of future improvement for this service in Ireland.
Introduction
A newborn hearing screening programme (NHSP) was implemented in Ireland in April 2011. It was introduced in the Southern region
of Ireland initially under the Health Service Executive (HSE) South at Cork University Maternity Hospital (CUMH). A phased roll-out
nationally of the screening programme was completed by November 2013 across all 20 maternity hospitals in the Republic of Ireland .
Since 2011, approximately 100 infants per year are diagnosed with a permanent childhood hearing impairment (PCHI) in Ireland
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through this programme . The ultimate goal of neonatal hearing screening is to reduce the age of diagnosis of hearing loss to three
months and to undertake/commence amplification, fitting and enrolment in early intervention programmes by 6 months of age. The
negative effects of hearing impairment can be reduced through effective intervention and management including hearing aid fitting,
rehabilitative interventions and language and family support.
Newborn hearing loss can result from conductive, sensorineural and mixed defects. All children diagnosed with a hearing impairment
should undergo aetiological investigations, the purpose of which is to determine the aetiology of hearing loss, to identify related
physical conditions, to provide recommendations for medical treatment as well as referral to other services and family counselling.
Following a diagnosis of PCHI, a recommended protocol to identify the aetiology is initiated in CUMH. This guideline was published by
the British Association of Paediatricians in Audiology and endorsed by the British Association of Audiological Physicians. In 2015,
BAAP guidelines were published for aetiological investigation into unilateral PCHI, bilateral severe to profound PCHI and mild to
moderate bilateral PCHI. The aim of this paper is to review the findings of the aetiological investigations performed on infants
diagnosed with PCHI in CUMH between April 2011 and July 2014.
Methods
Forty-two infants identified through the NHSP with a PCHI from April 2011 to July 2014 in CUMH were included in this study. PCHI
data was obtained from the eSP database. This is a web based information system (eSP) used to track each baby through the
screening and referral process All infants diagnosed with a PCHI in CUMH were referred to a designated paediatrician and followed a
UK guideline of aetiological investigations. A retrospective chart review of these patients was performed.
Results
Between April 2011 and July 2014, 27,812 infants were eligible for newborn hearing screening in CUMH and of these 27,451 (98.7%)
underwent hearing screening. Forty-two infants were identified with a PCHI between April 2011 and July 2014 in CUMH, 20 female
infants and 22 male infants. Figure 1 illustrates the types of hearing loss identified.
Two distinct hearing screening protocols are utilised in CUMH. One for well infants and one for infants admitted to the NICU for more
than 48 hours. Infants cared for in the NICU are at increased risk of neural hearing loss . The well baby protocol involves an
automated otoacoustic emission test (OAE). All NICU babies follow a two stage screening with OAE testing and auditory brainstem
response (ABR) testing in order to capture the higher incidence of hearing loss observed in this cohort. Eighteen (43%) infants were
screened using NICU protocol and 24 (57%), through the well baby protocol as per Figure 2.
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Of the 42 infants, 8 (19%) were born prematurely with gestational age ranging from 29 to 36 weeks. 6 (14%) of infants were classified
as Low Birth Weight infants (< 2.5kg) and 3 (7%) as Very Low Birth Weight infants (1.5-2.5kg).
There was no case of congenital rubella, syphilis or toxoplasma infection. Two (5%) babies were confirmed with a congenital
cytomegalovirus infection. An aminoglycoside was administered to 9 (21%) infants in the neonatal period, the most frequent of which
was gentamicin. There were no cases of viral or bacterial meningitis. Eleven (26%) had a positive family history for hearing loss, 8
(19%) of which were first degree relatives. There were no cases of consanguinity. Twenty-three electrocardiograms were performed,
all were reported as normal. Urinalysis was performed on 23 (55%) patients all of which were normal. Eight (19%) infants were
diagnosed with a specific genetic syndrome, as illustrated in Table 1.
Group
One (2%) baby has a confirmed DFNB1 mutation and two (5%) infants are heterozygous carriers of this mutation. The DFNB1 locus
contains genes that code for Connexin (transmembrane proteins that serve as potassium channels in the inner ear). Mutations of this
locus constitute the commonest genetic cause of non-syndromic deafness. One patient was found to have two alterations of the
SWLC26A4 gene. This gene translates to the protein Pendrin. Mutations of the genes coding for Pendrin are associated with sensori-
neural hearing loss, enlargement of the thyroid gland, enlargement of the vestibular aquaduct and malformation of the cochlea.
Nineteen (45%) of the 42 infants were assessed by Ophthalmology. Twelve (26%) assessments were reported as normal and 7 (17%)
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abnormal. Three of the 7 infants with an abnormal ophthalmology examination were diagnosed with a genetic syndrome, one baby
with Down Syndrome, one with Patau syndrome and one with Pfeiffer’s syndrome. Of the 14 babies (33%) MRI Brain studies
performed, 10 (23%) of which were reported as abnormal. Abnormalities included; hydrocephalus, structural malformations and
abnormal myelination patterns. An abnormal MRI Brain of an infant with congenital CMV infection demonstrated a
leukoencephalopathy with white matter cysts consistent for this infection.
Ten (23%) infants with bilaterally profound hearing loss were assessed for cochlear implantation. Five (12%) babies have undergone
cochlear implantation. Of the 10 infants with a profound bilateral hearing loss, two infants were confirmed with a genetic syndrome and
one with a connexion mutation. With regard to the 7 infants diagnosed with ANSD hearing loss, 5 (71%) were diagnosed with a
bilateral ANSD hearing loss and two (29%) with a unilateral ANSD hearing loss. Six out of 7 (85%) of this group were born prematurely
and all were admitted to the neonatal unit. Six of these infants had MRI Brain scans performed. Five were reported as abnormal with
reports describing extensive cystic periventriuclar leukomalacia and obstructive hydrocephalus. Two babies with ANSD hearing loss
were treated for significant sepsis in the neonatal period, one baby with Klebsiella and coagulase-negative staphylococcal (CONS)
sepsis and a second infant with E. Coli sepsis.
Discussion
From April 2011 to July 2014, the CUMH NHSP was successful in identifying PCHI in 42 infants, a prevalence of 1.5 per 1000 live
births. In CUMH, following the diagnosis of PCHI, all parents were offered detailed paediatric assessment. The referral for paediatric
review is initiated by the hospital audiologist once a definitive hearing diagnosis is made. Patients are seen within three to four months
due to demands on waiting lists. This pilot programme to establish the aetiology of PCHI commenced in CUMH utilised established UK
guidelines . Internationally, following an aetiological workup a cause for PCHI is identified in approximately 50% of cases . Early
diagnosis of PCHI has numerous benefits including facilitating interventions at a young age and improved language acquisition .
Every infant with a PCHI should be referred for medical evaluation. The purpose of these evaluations is to determine the aetiology of
hearing loss, to identify related physical conditions, and to provide recommendations for medical treatment as well as referral for other
services. Of great importance is cytomegalovirus (CMV) infection screening which must occur in a prompt fashion in order to facilitate
early initiation of Ganciclovir therapy for CMV positive infants. Other essential components of the medical evaluation include clinical
history, family history, and physical examination as well as indicated laboratory and radiologic studies.
At present there are no specific Irish guidelines for the aetiological work up of babies with a PCHI. There is no designated funding to
perform such diagnostic workups or specialised long-term follow up programme. Currently, in Ireland, we have established a structured
and efficient NHSP without establishing an equally cohesive follow up programme for babies diagnosed with a PCHI. This leads to
heterogeneous practice in terms of the aetiological investigation of infants identified with a PCHI across Ireland, where management of
such patients is dictated at a local level. Steps need to be put in place by the HSE to address these issues. However, this issue is not
unique to Ireland and several publications have called for a more unified approach to the management of these patients across various
European countries
Our review has demonstrated the benefit of adherence to a recommended protocol to identify the possible cause of PCHI. We accept
and recognise the deficits of this study, it was retrospective in nature, investigations were not performed based on the type or severity
of the hearing loss, every patient did not receive an ophthalmology review and urine collection was not ensured for cytomegalovirus
studies on every patient as patients did not always pass urine for testing at their outpatient appointment and were not consistently
followed up for a urine specimen.
The purpose of early screening and workup is to optimise an individual’s potential for integration into society and future employment.
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among stakeholders is established to ensure fair treatment and equal access for all with a PCHI to specialised services. This is an
opportunity to create such a structured, comprehensive approach to infants diagnosed with a PCHI though the Irish NHSP.
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